Study Says Bypass Surgery Beats Taxus Stent In Long-Run

September 2, 2008

A new clinical study carried out on the drug-coasted Taxus stent from Boston Scientific has found that the stent may not be the way to go for long-term health..Boston (ChattahBox) – A new clinical study carried out on the drug-coasted Taxus stent from Boston Scientific has found that the stent may not be the way to go for long-term health.

The study, known as SYNTAX, compared the drug-coated Taxus stemt to heart bypass surgery in treating clogged arteries.

Dutch researchers carried out the study and found interesting results.

They found that 17.8% of the patients who received stents either died, had a stroke, heart attack, or needed a repeat procedure, compared to only 12.1% who had heart bypass surgery.

Many in the medical field have long debated whether or not heart bypass surgery, or drug-coated stents were the way to go.  Both were found to be equally safe, but in the long-run it appears that heart bypass surgery is the better choice.

The study was presented at the annual meeting of the European Society of Cardiology.


Comments

Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.